Most recent update: Thursday, January 23, 2020 - 09:45

Bariatric News - Cookies & privacy policy

You are here


WHO research reveals variation of severe child obesity across Europe

New research from WHO Europe shows there is a wide gradient of severe child obesity across Europe, with countries in Southern Europe generally having the highest rates, according to a paper presented at this year's European Congress on Obesity in Glasgow, UK. The paper, led by Dr Angela Spinelli, National Institute of Health, Rome, Italy and colleagues across Europe, is part of the WHO Childhood Obesity Surveillance Initiative (COSI) led by Dr João Breda, Head of the WHO European Office for Prevention and Control of Noncommunicable Diseases, Moscow, Russia and his team.

Obesity undermining rising life expectancy in Europe

Although life expectancy in Europe continues to increase, obesity and the growing proportion of people who are overweight risks reversing this trend, according to a report by the World Health Organization. The ‘European Health Report’, covering 53 countries, found that the average life expectancy has increased from 76.7 years in 2010 to 77.8 years in 2015, with women expected to live longer than men - 81.1 years compared to 74.6 years, although the gap has slightly narrowed.

ReShape begins European Trial to support CE Mark for ReShape Vest

ReShape Lifesciences has commenced site initiation training for the first clinical trial site that will participate in the multi-centre trial of the ReShape Vest to support CE Mark approval. The trial, which will include study centres in Spain, Germany, Belgium, The Netherlands and the Czech Republic, seeks to enrol up to 95 subjects who will be followed for two years. Primary endpoints in this trial include percent total body weight loss and adverse event rates at 12 months. Enrolment is expected to begin in the third quarter of 2018.

KCI launches Abthera Advance Open Abdomen Dressing in Europe

KCI announced the availability of the Abthera Advance Open Abdomen Dressing in Europe, a next generation temporary abdominal closure device leveraging the technology of Abthera Open Abdomen Negative Pressure Therapy in bridging abdominal wall openings where primary closure is not possible and/or repeat abdominal entries are necessary.

Apollo establishes European endoscopic suturing registry

Apollo Endosurgery has announced the establishment of a multi-centre, longitudinal, data repository for Endoscopic Sleeve Gastroplasty (ESG) and gastrojejunal anastomotic outlet revision procedures. These endoscopic, trans-oral procedures allow physicians to place sutures in the upper gastrointestinal tract using a flexible endoscope to reduce stomach volume or revise previous bariatric surgery for patients. The prospective registry will collect outcomes related to the safety and effectiveness of procedures performed with Apollo’s OverStitch Endoscopic Suturing System.

Apollo Endosurgery gains CE Mark for Orbera365 System

Apollo Endosurgery has received the CE Mark approval for the Orbera365 Managed Weight Loss System, which doubles the indwell period of the Orbera intragastric balloon in the world from six months to a 12-month treatment period. The approval enables Apollo to market and sell the Orbera365 Weight Loss Balloon in European Union and the European Economic Area member countries. The Company expects Orbera365 to be commercially available starting in the fourth quarter of 2017.

Ethicon launches Echeleon Flex GST System (45mm) in Europe

Ethicon has launched its Echeleon Flex GST System (45mm) across Europe, building on the success of the Echelon Flex 60mm Powered Plus Stapler with Gripping Surface Technology (GST). The Echeleon Flex GST System now offers both 45mm and 60mm endocutters with reloads, which is of mounting importance as more complex surgeries are being performed through minimally invasive approaches.

EU Member States need to do more to tackle obesity

EU Member States are being called on to do more to tackle the growing obesity epidemic or they could face crippling costs of providing medical care in the future. The stark warning, and the call for more to be done to prevent and to treat the disease, comes from the European Association for the Study of Obesity (EASO).

According to EASO, too few European countries have effective strategies in place to tackle obesity and some have none at all.

CE Mark Approval for neoClose Laparoscopic Port Closure Device

neoSurgical has received CE Mark approval for the neoClose Laparoscopic Port Closure device, allowing the company to sell and distribute neoClose to the 28 countries in the European Economic Area. According to the company, neoClose brings a simple, intuitive and reliable solution to assist the surgeon in closing port site defects, up to 3cm, following laparoscopic abdominal surgery.  By utilising bio-absorbable anchors and a Vector-X closure, neoClose is changing the standard of care in port site closure. 

Children’s digestive health across Europe in crisis

A report investigating the current state of digestive health in children has revealed alarming trends in disease incidence and inequalities in the provision of digestive healthcare services for children across Europe. The report, ‘Paediatric Digestive Health Across Europe’, commissioned by United European Gastroenterology (UEG), highlights how the current health burden and economic pressure of paediatric digestive health issues, in particular the increasing levels of childhood obesity, have become a pandemic issue throughout the continent. 

Subscribe to RSS - europe